AmerisourceBergen Corporation

Pharmaceutical services firm reports earnings per share between $4 and $4.10

Published in Lab Business Week, February 6th, 2005

AmerisourceBergen Corporation's (ABC), CEO, R. David Yost, and senior VP and chief financial officer, Michael D. DiCandilo, speaking at the JP Morgan Healthcare Conference in San Francisco, confirmed that the company expects, as announced on December 15, 2004, diluted earnings per share from continuing operations for fiscal 2005 to be between $4.00 and $4.10.

They also affirmed, as previously announced, that the company expects diluted earnings per share from continuing operations from the recently completed December 2004 quarter to be $0.60 to $0.65.

The company continues to expect operating revenue growth in fiscal year 2005 to be flat, reflecting...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Lab Business Week

Source: Lab Business Week (2005-02-06)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry